The company expects gross margin for FY24 to fall within the range of 74%-75%. Pulmonx expects total operating expenses for FY24 to fall within the range of $132M-$134M, inclusive of approximately $30M of non-cash stock-based compensation.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on LUNG:
- Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer
- Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results
- Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024
